Allergic Rhinitis
Allergic Rhinitis
复制标题
过敏性鼻炎
DOI：
10.54543/kesans.v2i12.225
复制
发表时间：
2023
期刊：
影响因子：
--
通讯作者：
Ni Luh Eka Damayanti
中科院分区：
文献类型：
--
作者：
Ni Luh Eka Damayanti
变应性鼻炎（AR）是一种常见的慢性疾病，其特征是免疫球蛋白E（IgE）介导的吸入性过敏原反应。过敏性鼻炎（AR）经常与哮喘和结膜炎一起出现，并且它是一个重要的全球健康问题，在全球范围内造成了巨大的负担和障碍。过敏性鼻炎及其对哮喘的影响（ARIA）计划将过敏性鼻炎（AR）分为间歇性或慢性和轻度或中度/重度。诊断是通过对患者的临床病史、彻底的体格检查和适当的诊断测试进行全面评估来确定的。最常用的药物治疗包括口服、鼻内或眼部H1-抗组胺药、鼻内皮质类固醇或鼻内H1-抗组胺药和皮质类固醇的组合。
Allergic rhinitis (AR) is a common chronic illness worldwide, characterized by immunoglobulin E (IgE)-mediated reactions to inhaled allergens. Allergic rhinitis (AR) frequently presents alongside asthma and conjunctivitis, and it is a significant global health issue that imposes a substantial burden and handicap on a global scale. The classification of Allergic Rhinitis (AR) into intermittent or chronic and mild or moderate/severe was established by the Allergic Rhinitis and its Impact on Asthma (ARIA) program. The diagnosis is established through a comprehensive assessment of the patient's clinical history, thorough physical examination, and appropriate diagnostic tests. The pharmacological treatments most commonly employed consist of oral, intranasal, or ocular H1-antihistamines, intranasal corticosteroids, or a set combination of intranasal H1-antihistamines and corticosteroids.